Literature DB >> 13368432

The use of anthrax antigen to immunise man and monkey.

F C BELTON, H M DARLOW, D W HENDERSON.   

Abstract

Entities:  

Keywords:  ANTHRAX/immunology

Mesh：

Year:  1956        PMID： 13368432     DOI： 10.1016/s0140-6736(56)91968-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Field Evaluation of a Human Anthrax Vaccine.

Authors:  P S Brachman; H Gold; S A Plotkin; F R Fekety; M Werrin; N R Ingraham
Journal:  Am J Public Health Nations Health       Date:  1962-04

Review 2.  Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Authors:  Andrew J Phipps; Christopher Premanandan; Roy E Barnewall; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

3.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; M G Broster; J A Carman; R J Manchee; J Melling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

5.  Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.

Authors:  Kristin H Clement; Thomas L Rudge; Heather J Mayfield; Lena A Carlton; Arelis Hester; Nancy A Niemuth; Carol L Sabourin; April M Brys; Conrad P Quinn
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

6.  Highly effective generic adjuvant systems for orphan or poverty-related vaccines.

Authors:  Mangala Rao; Kristina K Peachman; Qin Li; Gary R Matyas; Sathish B Shivachandra; Richard Borschel; Venee I Morthole; Carmen Fernandez-Prada; Carl R Alving; Venigalla B Rao
Journal:  Vaccine       Date:  2010-11-27       Impact factor: 3.641

7.  Anthrax in the Gambia: an epidemiological study.

Authors:  B Heyworth; M E Ropp; U G Voos; H I Meinel; H M Darlow
Journal:  Br Med J       Date:  1975-10-11

8.  Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.

Authors:  Bruce K Brown; Josephine Cox; Anita Gillis; Thomas C VanCott; Mary Marovich; Mark Milazzo; Tanya Santelli Antonille; Lindsay Wieczorek; Kelly T McKee; Karen Metcalfe; Raburn M Mallory; Deborah Birx; Victoria R Polonis; Merlin L Robb
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

9.  Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).

Authors:  Mark S Lever; Anthony J Stagg; Michelle Nelson; Peter Pearce; Daniel J Stevens; Elizabeth A M Scott; Andrew J H Simpson; Mark J Fulop
Journal:  Int J Exp Pathol       Date:  2008-06       Impact factor: 1.925

10.  Studies on Immunity in Anthrax XII. Requirement for Phosphate for Elaboration of Protective Antigen and Its Partial Replacement by Charcoal.

Authors:  G G Wright; L H Angelety; B Swanson
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.